Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.32 |
| ▸ | ADRA2C | P18825 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9902809 | 0.92 | KDM4E (0.40) | KDM4EGAAKMT2AADRA2AADRA2B | |
| SCHEMBL9903038 | 0.85 | NOS1 (0.38) | KDM4EGAAKMT2A | |
| SCHEMBL9905760 | 0.81 | ADRA2A (0.33) | KDM4EGAAKMT2AADRA2AADRA2B | |
| SCHEMBL9902286 | 0.79 | KDM4E (0.35) | KDM4EGAAKMT2A | |
| SCHEMBL9902957 | 0.77 | KDM4E (0.37) | KDM4EGAAKMT2A | |
| SCHEMBL9901731 | 0.75 | KDM4E (0.35) | KDM4EGAAKMT2A | |
| SCHEMBL16994487 | 0.73 | KCNJ11 (0.33) | KDM4EGAAKMT2A | |
| SCHEMBL17271391 | 0.73 | KCNJ11 (0.33) | KDM4EGAAKMT2A | |
| SCHEMBL9902519 | 0.73 | KDM4E (0.39) | KDM4EGAAKMT2A | |
| SCHEMBL9902558 | 0.72 | KDM4E (0.37) | KDM4EGAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2649048-A1 | MULTIFUNCTIONAL NITROXIDE DERIVATIVES AND USES THEREOF | Radikal Therapeutics Inc. (US) | 2013-10-16 | — | — | EP | disclosed |
| WO-2012077108-A1 | MULTIFUNCTIONAL NITROXIDE DERIVATIVES AND USES THEREOF | RADIKAL THERAPEUTICS INC. (US) | 2012-06-14 | — | — | WO | disclosed |